Telmisartan, a possible PPAR-δ agonist, reduces TNF-α-stimulated VEGF-C production by inhibiting the p38MAPK/HSP27 pathway in human proximal renal tubular cells

This publication has 29 references indexed in Scilit:

• Suppression of heat shock protein 27 induces long-term dormancy in human breast cancer
  Proceedings of the National Academy of Sciences, 2012
• Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction
  Kidney International, 2012
• GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice
  PLOS ONE, 2011
• Angiotensin II receptor blocker telmisartan enhances running endurance of skeletal muscle through activation of the PPAR-δ/AMPK pathway
  Journal of Cellular and Molecular Medicine, 2010
• Inhibition of Tumor Necrosis Factor-α–Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer-Binding Protein-β
  Hypertension, 2009
• Lymphatic vessels develop during tubulointerstitial fibrosis
  Kidney International, 2009
• VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism
  Journal of Biological Chemistry, 2008
• Lymphangiogenesis in myocardial remodelling after infarction
  Histopathology, 2007
• Synergistic effect of hypoxia and TNF-α on production of PAI-1 in human proximal renal tubular cells
  Kidney International, 2005
• Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
  Hypertension, 2004